DBD: revenue and adjusted EBITDA up 5%, but FY26 profit and cash guidance cut
DBD grew third-quarter revenue and adjusted EBITDA 5%, but lowered its 2026 guidance for profit and free cash flow while authorizing a $250M buyback.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, DBD's third-quarter revenue and adjusted EBITDA each rose 5% year on year. The main driver was double-digit growth in the Retail business.
The company reduced its full-year 2026 guidance for adjusted EBITDA, free cash flow and earnings per share. At the same time, a $250M share buyback was authorized.
why it matters
A cut to cash-flow and profit guidance usually weighs on a stock more than quarterly top-line growth, so investors will look for management's explanation. The signal is mixed: business growth continues, but earnings expectations weakened, while the buyback offers some support.
market impact
DBD shares: lower profit and cash-flow guidance weighs on the stock
- DBD shares pressure down — lower 2026 profit and free cash flow guidance
tags
instruments
sources
- DBD: Revenue and adjusted EBITDA grew 5%, but FY26 profit and cash-flow guidance fell — TradingView, 28 October 2026 at 11:02 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗